RARA CRAFT DATABASE for FDA Medical Devices

FDA Device Decisions, March 2026: An Anti-Choking Device, a Transcatheter Valve for Aortic Regurgitation and More

日本語版

One of FDA's two De Novo grants in March 2026 went to LifeVac (DEN250012), a non-powered, single-use suction device for clearing a complete airway obstruction in a choking victim. Lay users can use it, but only as a second-line measure, when the current choking protocol has been followed without success.

The classification's special controls include postmarket surveillance and training. The manufacturer must keep reporting to FDA on frequency of use, delays in starting basic life support, success rates, injuries and malfunctions.

Counting records held in RA Craft Database (decisions through August 31, 2026, tallied October 6), FDA cleared 299 510(k)s in March 2026, granted 2 De Novo requests and approved 4 original PMAs, one of which, as explained below, was actually approved in 2014. These counts have not been reconciled with FDA's own figures. The site holds 510(k), De Novo and PMA records from 2015 onward, and counts for past months can change as the data are updated.

Counts by pathway

March 2026 next to the previous month and the same month a year earlier, with records assigned to a month by FDA decision date.

PathwayMarch 2026February 2026March 2025
510(k)299215239
De Novo222
PMA (original)450
PMA supplement170244178

Records held in RA Craft Database, decisions through August 31, 2026.

510(k) clearances were 84 more than in February and above March 2025 (239).

The busiest product codes

March's 510(k)s spread across 179 product codes. HRS (plate, fixation, bone) led with 13, followed by JAK (system, x-ray, tomography, computed) with 10, MBI (fastener, fixation, nondegradable, soft tissue) with 9 and QIH (automated radiological image processing software) with 8. GEX (powered laser surgical instrument), HSB (rod, fixation, intramedullary and accessories), ITI (wheelchair, powered) and OLO (orthopedic stereotaxic instrument) had 7 each. A single 510(k) can carry more than one product code, so per-code counts can add up to more than the number of submissions. If your code is on the list, enter it in the Product Code field on Search to see the records sorted by decision date.

De Novo: two devices for lay users

March's two De Novo grants, both Class II, with the classification names and regulation numbers from each Classification Order:

  • LifeVac (DEN250012, Lifevac, LLC): Suction anti-choking device as a second-line treatment (21 CFR 874.5400)
  • Tyto Insights for Eardrum Bulging Detection (DEN250014, Tyto Care, Ltd.): Ear, nose, and throat image analyzer (21 CFR 874.4775)

"21 CFR" refers to Title 21 of the Code of Federal Regulations, where FDA's regulations are codified.

Both are over-the-counter devices. Tyto Insights is AI-enabled software that automatically detects eardrum bulging in otoscopic video from a compatible electronic otoscope, in patients aged 6 months and older, and its indications state that it is not intended for diagnosis. Its four special controls include labeling that warns against using the device independently for diagnosis.

Original PMAs: three approvals (four on record)

Our count shows four original PMAs in March, but one of them, the REBEL Platinum Chromium Coronary Stent System (P130030, Boston Scientific), is a PMA whose approval order dates from 2014. It is counted in March because FDA's database shows a decision date of March 10, 2026; it was not newly approved in March. The three original PMAs actually approved in March were:

  • Claire™ OCT System (P250008, Perimeter Medical Imaging AI, Inc.): an adjunctive tool that images the margins of excised lumpectomy tissue with optical coherence tomography (OCT) and uses AI to mark areas suspicious for cancer (product code SHH)
  • Trilogy Transcatheter Heart Valve System (P250024, JenaValve Technology, Inc.): a transcatheter aortic valve for symptomatic severe aortic regurgitation in patients at high surgical risk (NPT)
  • aura6000 system (P250013, LivaNova USA, Inc.): an implanted stimulator of the proximal hypoglossal nerve for moderate to severe obstructive sleep apnea (MNQ)

March also brought 170 PMA supplements, which cover changes to already approved PMA devices among other things.

Three devices worth a closer read

1. LifeVac (DEN250012, De Novo). Its seven special controls cover premarket clinical information (frequency of use, delays in starting basic life support, success rates, injuries and malfunctions) and a postmarket surveillance study that tracks the same measures and reports to FDA periodically. Training is also required, including how to recognize airway obstruction and follow basic life support protocols. For an emergency device in lay hands, real-world performance and user education can become conditions of the classification.

2. Tyto Insights for Eardrum Bulging Detection (DEN250014, De Novo). Software that analyzes otoscope video recorded at home and flags eardrum bulging. The indications say it is not intended for diagnosis, and the labeling must warn against using it independently for diagnosis, which together limit how the output is used. As an over-the-counter AI classified through De Novo, its indications and labeling are worth reading closely.

3. Trilogy Transcatheter Heart Valve System (P250024, PMA). Most transcatheter aortic valves treat aortic stenosis; Trilogy is indicated for aortic regurgitation. According to the Summary of Safety and Effectiveness Data (SSED) that FDA published with the approval, the single-arm multicenter ALIGN-AR study enrolled 180 patients. Conditions of approval include following the study cohort to 10 years and a registry-based post-approval study of at least 2,000 patients, also followed to 10 years.

Compare the three devices

Open DEN250012, DEN250014 and P250024, star (☆) each one, tick "Compare" on all three in My Workspace and press "3 selected for comparison". The comparison table puts their Indications for Use side by side. Before relying on any of this, open "FDA Record" and "Summary PDF" on each record and read the source.

Note: months are assigned by FDA decision date, and counts can change as the data are updated each month.

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles